Severe but newly diagnosed cardiometabolic derangements do not preclude safe myomectomy. Structured, time-limited optimization with multidisciplinary input allows surgery to proceed once cardiovascular risk is controlled, even if glycemic targets remain imperfectly met.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: